Partnering with Vipergen
Vipergen is actively seeking to enter into drug discovery alliances with leading pharmaceutical and biotechnology companies taking innovative initiatives to make breakthroughs for their toughest projects.
We offer different business models, including simple Fee-For-Service.
Partner with us
From straightforward Fee-For-Service to comprehensive joint ventures, we provide flexible partnership structures to align with your project’s distinct needs.
Why partner with Vipergen?
- Identify hits and hit families delivering SAR for instant evaluation of functional groups critical to the binding interaction
- Instant selectivity by multiplexed screen against target and anti-targets (unique capability)
- Low false positive rates (100% match between code and compound)
- Screening in homogeneous assay (unique capability)
- Screening in living cells – no requirement for purified target protein (unique capability)
- Appropriate across therapeutic areas for soluble proteins (no structural information required)
- Demonstrated ability to address difficult targets, including transcription factors, protein complexes, and PPI
- Proven track record, in 2015-23 >85 deals signed, including with top-5 pharma in both USA, EU and Japan
Drug discovery with our pioneering approach
Vipergen will leverage its proprietary yR, BTE and cBTE technologies for the discovery of hits for its partners’ important therapeutic targets.
The scalability of the technology makes it particularly suitable for projects which can benefit from establishing specificity profiles on a range of targets or kinetic profiles of hits and Vipergen welcomes partners wishing to explore these capabilities.
Vipergen is also seeking to enter into joint ventures with companies having complementary technology or expertise.
If interested in potential alliances and collaborations to address your drug-discovery challenges contact us at: [email protected]
Vipergen ApS
Gammel Kongevej 23A, 1st floor
DK-1610 Copenhagen
Denmark
Phone: +45 2523 6680
[email protected]
General information, partnering, jobs.
CVR NO: 28851758